JNJ
JNJ
NEW YORK STOCK EXCHANGE, INC. · Pharmaceuticals

Johnson & Johnson

$231.29
+2.90 (+1.27%)
As of Jun 22, 9:30 PM ET ·
Analyst Consensus
Buy
31
Analysts
Very High
Coverage
Buy 21 68%
Hold 10 32%
Sell 0 0%
Price Target
Analyst Price Target +29.5% upside
Low Target $223.02
Average Target $299.55
High Target $400.15
Current Price $231.29
Current
$231.29
Target
$299.55
$223.02 $299.55 avg $400.15
Scenario Analysis
Bear Case
$223.02
-3.6%
Low target
Base Case
$299.55
+29.5%
Avg target
Bull Case
$400.15
+73.0%
High target
Risk/Reward
20.4x
Highly favorable
Price in Context
52-Week High
$251.71
-8.1% from high
52-Week Low
$149.04
+55.2% from low
50-Day SMA
$219.25
+5.5% vs SMA
200-Day SMA
$185.17
+24.9% vs SMA
RSI (14)
88.6
Overbought
Target vs 52W High
$299.55
+19.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.7%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +29.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +37.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +35.2%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +219.0%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +176.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -32.3%